Posts by: Joana Carvalho, MSc

Joana Carvalho, MSc

Joana holds a BSc in Biology and a MSc in Evolutionary and Developmental Biology from Universidade de Lisboa. She is currently finishing her PhD in Biomedicine and Clinical Research at Universidade de Lisboa. Her work has been focused on the impact of non-canonical Wnt signaling in the collective behavior of endothelial cells — cells that made up the lining of blood vessels — found in the umbilical cord of newborns.

October 29, 2019October 29, 2019

Duaklir Now Available to COPD Patients in US, Circassia Announces

News

Duaklir (aclidinium bromide and formoterol fumarate), a long-term maintenance treatment for chronic obstructive pulmonary disease (COPD), is available to patients living in the U.S., Circassia Pharmaceuticals announced. According to ... Read more

October 25, 2019October 25, 2019

Tudorza Reduces COPD Flare-ups Without Increasing Risk of Cardiovascular Complications or Death, Phase 4 Trial Shows

News

Tudorza (aclidinium bromide) reduces flare-ups in patients with moderate to severe chronic obstructive pulmonary disease (COPD) without increasing the risk of cardiovascular complications such as heart attack and stroke, ... Read more

September 24, 2019September 24, 2019

Vaping Triggers Cellular Responses Similar to Cigarette Smoking, Potentially Increasing Risk of Emphysema

News

The use of electronic cigarettes, more commonly known as vaping, triggers cellular responses in the lungs similar to those elicited by smoking tobacco cigarettes, which may place e-cigarette users ... Read more

August 27, 2019August 27, 2019

COPD Patients With Acute Exacerbations Should Receive Noninvasive Ventilation Regardless of Certain Characteristics, Study Suggests

News

Patients with chronic obstructive pulmonary disease (COPD) who are experiencing severe exacerbations should receive noninvasive ventilation, regardless of factors such as older age, low body mass index (BMI), left ... Read more

August 20, 2019August 20, 2019

Findings of 3 Studies of Nerve Ablation Therapy in COPD Patients to Appear in Science Journals, Nuvaira Says

News

Nuvaira, a medical device company, announced the upcoming publication of several scientific studies detailing the findings of clinical trials that assessed the safety and effectiveness of its Targeted Lung Denervation ... Read more

August 13, 2019August 13, 2019

Spiration Valve System Helps People with Severe Emphysema Breathe More Easily, Study Finds

News

Olympus‘ Spiration Valve System (SVS), a device that can be inserted into a patient’s airways to redirect air from diseased regions of the lungs and toward its healthier parts, ... Read more

July 2, 2019July 2, 2019

COPD Patients at Greater Risk of Fractures and Osteoporosis Than Those with Other Diseases, UK Study Finds

News

Patients with chronic obstructive pulmonary disease (COPD) are more susceptible to bone fractures and osteoporosis than those of the same age and sex without this disease, a study reports. The ... Read more

April 12, 2019April 12, 2019

CSA Medical’s RejuvenAir System Gets FDA Breakthrough Device Designation

News

CSA Medical‘s RejuvenAir System received the designation of Breakthrough Device by the U.S. Food and Drug Administration (FDA) for the treatment of patients with chronic obstructive pulmonary disease (COPD). The ... Read more

April 9, 2019

Circassia Adding Cardiovascular Safety Data on Tudorza Label for COPD Patients

News

The U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application for the addition of new clinical data on on the label of Tudorza (aclidinium bromide), ... Read more

October 19, 2018October 19, 2018

FDA Approves New Label for Stiolto Respimat Showing Efficacy Against COPD Flare-ups

News

The U.S. Food and Drug Administration (FDA) approved a new label for Stiolto Respimat (a combination therapy of tiotropium bromide and olodaterol) based on data from clinical trials showing ... Read more

Pin It on Pinterest